» Articles » PMID: 36280799

The Neural Basis of Psychedelic Action

Overview
Journal Nat Neurosci
Date 2022 Oct 25
PMID 36280799
Authors
Affiliations
Soon will be listed here.
Abstract

Psychedelics are serotonin 2A receptor agonists that can lead to profound changes in perception, cognition and mood. In this review, we focus on the basic neurobiology underlying the action of psychedelic drugs. We first discuss chemistry, highlighting the diversity of psychoactive molecules and the principles that govern their potency and pharmacokinetics. We describe the roles of serotonin receptors and their downstream molecular signaling pathways, emphasizing key elements for drug discovery. We consider the impact of psychedelics on neuronal spiking dynamics in several cortical and subcortical regions, along with transcriptional changes and sustained effects on structural plasticity. Finally, we summarize neuroimaging results that pinpoint effects on association cortices and thalamocortical functional connectivity, which inform current theories of psychedelic action. By synthesizing knowledge across the chemical, molecular, neuronal, and network levels, we hope to provide an integrative perspective on the neural mechanisms responsible for the acute and enduring effects of psychedelics on behavior.

Citing Articles

Transient destabilization of whole brain dynamics induced by N,N-Dimethyltryptamine (DMT).

Piccinini J, Sanz Perl Y, Pallavicini C, Deco G, Kringelbach M, Nutt D Commun Biol. 2025; 8(1):409.

PMID: 40069397 PMC: 11897362. DOI: 10.1038/s42003-025-07576-0.


Low-Dose LSD Alters Early and Late Event-Related Potentials to Emotional Faces.

Haggarty C, Molla H, Glazer J, Tare I, Rains A, de Wit H Psychedelic Med (New Rochelle). 2025; 2(4):210-220.

PMID: 40051483 PMC: 11658383. DOI: 10.1089/psymed.2024.0005.


Licit use of illicit drugs for treating depression: the pill and the process.

Torrado Pacheco A, Moghaddam B J Clin Invest. 2025; 134(12).

PMID: 40047885 PMC: 11178541. DOI: 10.1172/JCI180217.


A Heuristic Approach: Against Consensus Definitions of Psychedelics.

Lepow L, Kronman H, Yehuda R Psychedelic Med (New Rochelle). 2025; 1(4):190-194.

PMID: 40046859 PMC: 11658663. DOI: 10.1089/psymed.2023.0031.


A cell type-specific mechanism driving the rapid antidepressant effects of transcranial magnetic stimulation.

W Gongwer M, Qi A, Enos A, Rueda S, Rueda Mora S, Klune C bioRxiv. 2025; .

PMID: 39975365 PMC: 11838264. DOI: 10.1101/2025.01.29.635537.


References
1.
Nichols D, Walter H . The History of Psychedelics in Psychiatry. Pharmacopsychiatry. 2020; 54(4):151-166. DOI: 10.1055/a-1310-3990. View

2.
Davis A, Barrett F, May D, Cosimano M, Sepeda N, Johnson M . Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial. JAMA Psychiatry. 2020; 78(5):481-489. PMC: 7643046. DOI: 10.1001/jamapsychiatry.2020.3285. View

3.
Carhart-Harris R, Giribaldi B, Watts R, Baker-Jones M, Murphy-Beiner A, Murphy R . Trial of Psilocybin versus Escitalopram for Depression. N Engl J Med. 2021; 384(15):1402-1411. DOI: 10.1056/NEJMoa2032994. View

4.
Johnson M, Garcia-Romeu A, Griffiths R . Long-term follow-up of psilocybin-facilitated smoking cessation. Am J Drug Alcohol Abuse. 2016; 43(1):55-60. PMC: 5641975. DOI: 10.3109/00952990.2016.1170135. View

5.
Nichols D . Psychedelics. Pharmacol Rev. 2016; 68(2):264-355. PMC: 4813425. DOI: 10.1124/pr.115.011478. View